nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Nilutamide—prostate cancer	0.214	0.294	CbGbCtD
Sulfisoxazole—CYP2C9—Bicalutamide—prostate cancer	0.214	0.294	CbGbCtD
Sulfisoxazole—CYP2C9—Estrone—prostate cancer	0.128	0.176	CbGbCtD
Sulfisoxazole—CYP2C9—Capecitabine—prostate cancer	0.097	0.134	CbGbCtD
Sulfisoxazole—CYP2C9—Estradiol—prostate cancer	0.0735	0.101	CbGbCtD
Sulfisoxazole—EDNRA—prostate gland—prostate cancer	0.00869	0.238	CbGeAlD
Sulfisoxazole—CYP2C9—urine—prostate cancer	0.00801	0.22	CbGeAlD
Sulfisoxazole—EDNRA—seminal vesicle—prostate cancer	0.00735	0.202	CbGeAlD
Sulfisoxazole—EDNRA—urethra—prostate cancer	0.00582	0.16	CbGeAlD
Sulfisoxazole—Sulfamethoxazole—NAT1—prostate cancer	0.00424	0.327	CrCbGaD
Sulfisoxazole—EDNRA—testis—prostate cancer	0.00383	0.105	CbGeAlD
Sulfisoxazole—EDNRA—lymph node—prostate cancer	0.00278	0.0761	CbGeAlD
Sulfisoxazole—Sulfamethoxazole—NAT2—prostate cancer	0.00134	0.103	CrCbGaD
Sulfisoxazole—Sulfathiazole—CYP19A1—prostate cancer	0.00121	0.0933	CrCbGaD
Sulfisoxazole—Dapsone—NAT2—prostate cancer	0.00104	0.0805	CrCbGaD
Sulfisoxazole—Dapsone—CYP2C18—prostate cancer	0.000664	0.0512	CrCbGaD
Sulfisoxazole—Sulfaphenazole—CYP2A6—prostate cancer	0.000639	0.0492	CrCbGaD
Sulfisoxazole—Sulfadiazine—CYP2E1—prostate cancer	0.000496	0.0382	CrCbGaD
Sulfisoxazole—Dapsone—MPO—prostate cancer	0.000494	0.0381	CrCbGaD
Sulfisoxazole—Dapsone—CYP3A5—prostate cancer	0.000437	0.0337	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP2E1—prostate cancer	0.000337	0.026	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP2C19—prostate cancer	0.000333	0.0257	CrCbGaD
Sulfisoxazole—Sulfadiazine—CYP3A4—prostate cancer	0.000312	0.0241	CrCbGaD
Sulfisoxazole—Dapsone—CYP2E1—prostate cancer	0.0003	0.0232	CrCbGaD
Sulfisoxazole—Dapsone—CYP2C19—prostate cancer	0.000298	0.0229	CrCbGaD
Sulfisoxazole—Sulfamethoxazole—CYP3A4—prostate cancer	0.000242	0.0186	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP3A4—prostate cancer	0.000212	0.0163	CrCbGaD
Sulfisoxazole—Dapsone—CYP3A4—prostate cancer	0.000189	0.0146	CrCbGaD
Sulfisoxazole—Dapsone—PTGS2—prostate cancer	0.000185	0.0143	CrCbGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ITPR1—prostate cancer	0.000133	0.000592	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIST1H4H—prostate cancer	0.000133	0.00059	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL8—prostate cancer	0.000133	0.000589	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.000132	0.000587	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—NCOA1—prostate cancer	0.000132	0.000587	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP19A1—prostate cancer	0.00013	0.000578	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GNG5—prostate cancer	0.00013	0.000575	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP19A1—prostate cancer	0.000128	0.00057	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—RXRA—prostate cancer	0.000126	0.000558	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.000126	0.000558	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.000122	0.000542	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—COMT—prostate cancer	0.000121	0.000537	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—prostate cancer	0.00012	0.000535	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—COMT—prostate cancer	0.000119	0.00053	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.000119	0.000529	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—prostate cancer	0.000119	0.000528	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.000114	0.000504	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.000114	0.000504	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFBR1—prostate cancer	0.000113	0.000501	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTHLH—prostate cancer	0.000113	0.000501	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKR1C3—prostate cancer	0.000111	0.000493	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—prostate cancer	0.000111	0.000492	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKACB—prostate cancer	0.00011	0.000491	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—prostate cancer	0.000109	0.000485	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PPP3CA—prostate cancer	0.000108	0.000478	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—THBS1—prostate cancer	0.000108	0.000478	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ANXA1—prostate cancer	0.000106	0.000471	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP1A1—prostate cancer	0.000105	0.000466	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCZ—prostate cancer	0.000104	0.000463	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HAO1—prostate cancer	0.000104	0.00046	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP1A1—prostate cancer	0.000103	0.00046	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CG—prostate cancer	0.000102	0.000452	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGFR4—prostate cancer	0.000101	0.000447	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PARP1—prostate cancer	0.000101	0.000447	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CALCA—prostate cancer	9.94e-05	0.000441	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL12—prostate cancer	9.71e-05	0.000431	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	9.65e-05	0.000429	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	9.26e-05	0.000411	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CG—prostate cancer	9.25e-05	0.000411	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP9—prostate cancer	9.14e-05	0.000406	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CD—prostate cancer	8.95e-05	0.000398	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	8.91e-05	0.000396	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCQ—prostate cancer	8.86e-05	0.000393	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NGFR—prostate cancer	8.86e-05	0.000393	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAP3K7—prostate cancer	8.75e-05	0.000389	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	8.6e-05	0.000382	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADI1—prostate cancer	8.44e-05	0.000375	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GRHL1—prostate cancer	8.44e-05	0.000375	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PSAT1—prostate cancer	8.44e-05	0.000375	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CSAD—prostate cancer	8.44e-05	0.000375	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CBR1—prostate cancer	8.44e-05	0.000375	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TST—prostate cancer	8.44e-05	0.000375	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF10—prostate cancer	8.42e-05	0.000374	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRB2—prostate cancer	8.33e-05	0.00037	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	8.25e-05	0.000366	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—JAK2—prostate cancer	8.21e-05	0.000365	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAP2K1—prostate cancer	8.18e-05	0.000363	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CD—prostate cancer	8.13e-05	0.000361	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VAV3—prostate cancer	8.12e-05	0.000361	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	8.09e-05	0.000359	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFBR2—prostate cancer	8e-05	0.000356	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITPR1—prostate cancer	7.88e-05	0.00035	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GRHPR—prostate cancer	7.85e-05	0.000349	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UGT2B17—prostate cancer	7.85e-05	0.000349	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CKMT2—prostate cancer	7.85e-05	0.000349	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UGT2B15—prostate cancer	7.85e-05	0.000349	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CB—prostate cancer	7.8e-05	0.000347	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	7.67e-05	0.000341	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	7.54e-05	0.000335	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1R—prostate cancer	7.53e-05	0.000335	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL8—prostate cancer	7.5e-05	0.000333	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—JAK2—prostate cancer	7.46e-05	0.000331	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NAGLU—prostate cancer	7.38e-05	0.000328	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MBTPS1—prostate cancer	7.38e-05	0.000328	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—RFK—prostate cancer	7.38e-05	0.000328	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AOX1—prostate cancer	7.38e-05	0.000328	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM3—prostate cancer	7.38e-05	0.000328	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PGAM2—prostate cancer	7.38e-05	0.000328	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SULT2B1—prostate cancer	7.38e-05	0.000328	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LPL—prostate cancer	7.22e-05	0.000321	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	7.21e-05	0.00032	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—prostate cancer	7.16e-05	0.000318	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFRB—prostate cancer	7.16e-05	0.000318	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CB—prostate cancer	7.08e-05	0.000315	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP3A43—prostate cancer	6.99e-05	0.000311	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AMACR—prostate cancer	6.99e-05	0.000311	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SRD5A2—prostate cancer	6.99e-05	0.000311	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DEGS1—prostate cancer	6.99e-05	0.000311	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NAT1—prostate cancer	6.99e-05	0.000311	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITGB3—prostate cancer	6.97e-05	0.00031	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	6.88e-05	0.000306	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	6.84e-05	0.000304	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL8—prostate cancer	6.81e-05	0.000302	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB3—prostate cancer	6.76e-05	0.0003	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGFR2—prostate cancer	6.75e-05	0.0003	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSD17B1—prostate cancer	6.67e-05	0.000296	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	6.67e-05	0.000296	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—prostate cancer	6.51e-05	0.000289	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TERT—prostate cancer	6.48e-05	0.000288	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	6.42e-05	0.000285	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	6.38e-05	0.000283	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	6.32e-05	0.000281	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIF1A—prostate cancer	6.2e-05	0.000275	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LEP—prostate cancer	6.05e-05	0.000269	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	6.02e-05	0.000267	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CAV1—prostate cancer	6e-05	0.000266	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HPGD—prostate cancer	5.95e-05	0.000264	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—B4GALT4—prostate cancer	5.95e-05	0.000264	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—prostate cancer	5.93e-05	0.000263	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ESR1—prostate cancer	5.78e-05	0.000257	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BAD—prostate cancer	5.64e-05	0.00025	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TNFRSF21—prostate cancer	5.59e-05	0.000248	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APC—prostate cancer	5.46e-05	0.000243	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CG—prostate cancer	5.46e-05	0.000243	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP7B1—prostate cancer	5.44e-05	0.000242	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTAP—prostate cancer	5.44e-05	0.000242	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGF—prostate cancer	5.4e-05	0.00024	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IRS1—prostate cancer	5.4e-05	0.00024	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.32e-05	0.000236	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SULT1E1—prostate cancer	5.3e-05	0.000235	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SRD5A1—prostate cancer	5.3e-05	0.000235	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GSK3B—prostate cancer	5.24e-05	0.000233	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—INS—prostate cancer	5.17e-05	0.00023	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.15e-05	0.000229	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.07e-05	0.000225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CREBBP—prostate cancer	5.06e-05	0.000225	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACSL4—prostate cancer	5.06e-05	0.000225	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSD17B3—prostate cancer	5.06e-05	0.000225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1—prostate cancer	5e-05	0.000222	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	5e-05	0.000222	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—prostate cancer	4.98e-05	0.000221	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PHGDH—prostate cancer	4.85e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UMPS—prostate cancer	4.85e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ARG2—prostate cancer	4.85e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAP2K1—prostate cancer	4.83e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	4.82e-05	0.000214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CD—prostate cancer	4.8e-05	0.000213	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—prostate cancer	4.76e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LDHB—prostate cancer	4.75e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SERPINE1—prostate cancer	4.75e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KRAS—prostate cancer	4.7e-05	0.000209	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP3A5—prostate cancer	4.67e-05	0.000207	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF2—prostate cancer	4.6e-05	0.000204	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOS3—prostate cancer	4.53e-05	0.000201	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TCN2—prostate cancer	4.51e-05	0.0002	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA3—prostate cancer	4.51e-05	0.0002	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UCP3—prostate cancer	4.51e-05	0.0002	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PDHA1—prostate cancer	4.51e-05	0.0002	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JAK2—prostate cancer	4.41e-05	0.000196	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—prostate cancer	4.32e-05	0.000192	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MDM2—prostate cancer	4.3e-05	0.000191	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSD3B1—prostate cancer	4.3e-05	0.000191	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC22A3—prostate cancer	4.3e-05	0.000191	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB2—prostate cancer	4.24e-05	0.000188	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CB—prostate cancer	4.19e-05	0.000186	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.17e-05	0.000185	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA4—prostate cancer	4.12e-05	0.000183	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TBXAS1—prostate cancer	4.12e-05	0.000183	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.03e-05	0.000179	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL8—prostate cancer	4.02e-05	0.000179	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA2—prostate cancer	4.02e-05	0.000178	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCG5—prostate cancer	3.97e-05	0.000176	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SULT1A1—prostate cancer	3.97e-05	0.000176	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1B—prostate cancer	3.93e-05	0.000174	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—prostate cancer	3.89e-05	0.000173	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA1—prostate cancer	3.88e-05	0.000172	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—prostate cancer	3.85e-05	0.000171	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—prostate cancer	3.84e-05	0.000171	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSD3B2—prostate cancer	3.83e-05	0.00017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTO1—prostate cancer	3.83e-05	0.00017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NAT2—prostate cancer	3.83e-05	0.00017	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—prostate cancer	3.82e-05	0.00017	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCND1—prostate cancer	3.75e-05	0.000166	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CTNNB1—prostate cancer	3.71e-05	0.000165	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.68e-05	0.000164	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCB2—prostate cancer	3.67e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LRP2—prostate cancer	3.67e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2C18—prostate cancer	3.67e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—prostate cancer	3.64e-05	0.000162	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1A—prostate cancer	3.62e-05	0.000161	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTEN—prostate cancer	3.62e-05	0.000161	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—P4HB—prostate cancer	3.6e-05	0.00016	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—prostate cancer	3.53e-05	0.000157	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC22A1—prostate cancer	3.5e-05	0.000156	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.46e-05	0.000154	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EP300—prostate cancer	3.45e-05	0.000153	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SULT2A1—prostate cancer	3.42e-05	0.000152	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MED12—prostate cancer	3.36e-05	0.000149	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SRC—prostate cancer	3.35e-05	0.000149	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GNG5—prostate cancer	3.33e-05	0.000148	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—prostate cancer	3.27e-05	0.000145	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—prostate cancer	3.23e-05	0.000144	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOA3—prostate cancer	3.21e-05	0.000143	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.16e-05	0.00014	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HPGDS—prostate cancer	3.06e-05	0.000136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2C19—prostate cancer	3.04e-05	0.000135	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYC—prostate cancer	3.01e-05	0.000133	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFB1—prostate cancer	3e-05	0.000133	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACHE—prostate cancer	2.97e-05	0.000132	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—prostate cancer	2.97e-05	0.000132	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—prostate cancer	2.94e-05	0.000131	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2A6—prostate cancer	2.94e-05	0.00013	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.93e-05	0.00013	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKR1C3—prostate cancer	2.86e-05	0.000127	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PRKACB—prostate cancer	2.84e-05	0.000126	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP17A1—prostate cancer	2.81e-05	0.000125	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KRAS—prostate cancer	2.78e-05	0.000123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.77e-05	0.000123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOA2—prostate cancer	2.68e-05	0.000119	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.56e-05	0.000114	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—prostate cancer	2.55e-05	0.000113	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.5e-05	0.000111	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NQO1—prostate cancer	2.47e-05	0.00011	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—prostate cancer	2.47e-05	0.00011	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TH—prostate cancer	2.43e-05	0.000108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.42e-05	0.000107	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.41e-05	0.000107	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.4e-05	0.000106	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.37e-05	0.000105	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GGT1—prostate cancer	2.29e-05	0.000102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—prostate cancer	2.26e-05	0.0001	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOA1—prostate cancer	2.26e-05	0.0001	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.23e-05	9.89e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—RXRA—prostate cancer	2.15e-05	9.54e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.09e-05	9.28e-05	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—prostate cancer	2.08e-05	9.26e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COMT—prostate cancer	2.07e-05	9.19e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—prostate cancer	2.06e-05	9.15e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ITPR1—prostate cancer	2.03e-05	9e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.99e-05	8.85e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TYMS—prostate cancer	1.91e-05	8.5e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—prostate cancer	1.89e-05	8.41e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LPL—prostate cancer	1.86e-05	8.25e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.79e-05	7.97e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ERCC2—prostate cancer	1.78e-05	7.9e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—prostate cancer	1.67e-05	7.43e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARA—prostate cancer	1.64e-05	7.29e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAV1—prostate cancer	1.54e-05	6.85e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.47e-05	6.55e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.41e-05	6.24e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—INS—prostate cancer	1.33e-05	5.91e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CREBBP—prostate cancer	1.3e-05	5.79e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.24e-05	5.49e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NOS3—prostate cancer	1.17e-05	5.18e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.08e-05	4.78e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—prostate cancer	1.07e-05	4.74e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTEN—prostate cancer	9.3e-06	4.13e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—EP300—prostate cancer	8.87e-06	3.94e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—prostate cancer	6.56e-06	2.92e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—prostate cancer	5.36e-06	2.38e-05	CbGpPWpGaD
